Hippo (NYSE:HIPO) CEO Richard Mccathron Sells 5,000 Shares

Hippo Holdings Inc. (NYSE:HIPO) CEO Richard Mccathron sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The stock was sold at an average price of $29.14, for a total transaction of $145,700.00. Following the completion of the sale, the chief executive officer directly owned 442,704 shares of the company’s stock, valued at $12,900,394.56. The trade was a 1.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Richard Mccathron also recently made the following trade(s):

• On Friday, January 9th, Richard Mccathron sold 5,000 shares of Hippo stock. The stock was sold at an average price of $31.52, for a total transaction of $157,600.00.
• On Tuesday, December 9th, Richard Mccathron sold 5,000 shares of Hippo stock. The shares were sold at an average price of $29.82, for a total value of $149,100.00.

Hippo Trading Down 2.0%

Shares of NYSE:HIPO opened at $27.75 on Thursday. The company has a market capitalization of $703.15 million, a PE ratio of 7.67 and a beta of 1.57. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.11. Hippo Holdings Inc. has a 12-month low of $19.92 and a 12-month high of $38.98. The business’s fifty day simple moving average is $30.48 and its 200-day simple moving average is $32.50.

Hedge Funds Weigh In On Hippo

Hedge funds have recently made changes to their positions in the company. Hood River Capital Management LLC purchased a new stake in shares of Hippo in the second quarter worth about $13,665,000. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Hippo during the 3rd quarter worth approximately $5,842,000. Geode Capital Management LLC increased its holdings in shares of Hippo by 24.1% during the 4th quarter. Geode Capital Management LLC now owns 557,066 shares of the company’s stock valued at $16,760,000 after purchasing an additional 108,359 shares in the last quarter. Sei Investments Co. acquired a new stake in Hippo during the second quarter valued at $2,810,000. Finally, Nuveen LLC increased its holdings in Hippo by 238.6% in the fourth quarter. Nuveen LLC now owns 140,527 shares of the company’s stock valued at $4,227,000 after buying an additional 99,020 shares in the last quarter. 43.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HIPO has been the topic of a number of recent analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Hippo in a report on Thursday, January 22nd. Zacks Research raised shares of Hippo from a “hold” rating to a “strong-buy” rating in a research report on Friday, November 14th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of Hippo from $33.00 to $34.00 and gave the stock a “market perform” rating in a report on Wednesday, December 10th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Hippo presently has a consensus rating of “Moderate Buy” and an average target price of $37.50.

About Hippo

Hippo Enterprises Inc is a technology-driven home insurance company that offers modernized homeowners insurance products through a digital-first platform. Leveraging data analytics, artificial intelligence and smart home devices, the company designs tailored coverage plans intended to streamline the underwriting process and deliver more comprehensive protection for homeowners. Hippo’s policies typically include standard dwelling coverage, personal property protection and liability insurance, along with optional add-ons such as water backup, home computer systems and equipment breakdown coverage.

Through its online portal and partner network of licensed insurance agents, Hippo provides policyholders with a range of services aimed at minimizing risk and preventing losses before they occur.